The remaining substances (escitalopram, sertraline, mirtazapine, duloxetine, venlafaxine, fluvoxamine, vortioxetine, trazodone, and bupropion) exhibited an increasing trend (Supplemental Figure 1 (Supplementary Figure 1) ).
← all excerpts
Antidepressant prescribing pattern in Croatia: a retrospective, longitudinal study from 2017 to 2022.
1
—
—